Year-End Report — PODESTA GROUP, INC. for GENZYME (2007)

Firm

PODESTA GROUP, INC.

Client

GENZYME

Income

$80,000

Expenses

—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H. R. 976, Small Business Tax Relief Act of 2007 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion S. 1893, Children's Health Insurance Program Reauthorization Act of 2007 S. 2499, Medicare, Medicaid, and SCHIP Extension Act of 2007 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. R. 3162, Children's Health and Medicare Protection Act of 2007

Lobbyist	Covered position, as disclosed
PAUL BRATHWAITE	EXEC. DIR., CONGRESSIONAL BLACK CAUCUS
SHARON COHEN	N/A
RANDALL GERARD	N/A
COURTNEY HAGEN	N/A
AMANDA HUNTLEY	N/A
ANDREW KAUDERS	SR. ADV. SEN. MENENDEZ; ED, HOUSE DEM CAUCUS
ELIZABETH ANN MORRA	N/A
ANTHONY PODESTA	N/A
ANNE MARIE POLAK	LEG. CORRESPONDENT FOR REP. MIKE FERGUSON
LANTIE SLENZAK	LEGISLATIVE DIRECTOR, REP. GENE GREEN

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2499 (110th), H.R. 3162 (110th), S. 3 (110th), S. 1893 (110th), H.R. 4 (110th), S. 1376 (110th), H.R. 2606 (110th), H.R. 976 (110th)

Budget/Appropriations BUD

S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare provisions H. R. 2764, Foreign Operations and Related Programs Appropriations Act, 2008, (Division A, Division G) H. R. 3043, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare provisions

Lobbyist	Covered position, as disclosed
PAUL BRATHWAITE	EXEC. DIR., CONGRESSIONAL BLACK CAUCUS
SHARON COHEN	N/A
RANDALL GERARD	N/A
COURTNEY HAGEN	N/A
AMANDA HUNTLEY	N/A
ANDREW KAUDERS	SR. ADV. SEN. MENENDEZ; ED, HOUSE DEM CAUCUS
ELIZABETH ANN MORRA	N/A
ANTHONY PODESTA	N/A
ANNE MARIE POLAK	LEG. CORRESPONDENT FOR REP. MIKE FERGUSON
LANTIE SLENZAK	LEGISLATIVE DIRECTOR, REP. GENE GREEN

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: S. 1710 (110th), H.R. 3043 (110th), H.R. 2764 (110th)

Pharmacy PHA

H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions H. R. 3580, Food and Drug Administration Amendments Act of 2007 S. 1024, Safer DATA Act, clinical trials/drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 4, Improving America's Security Act of 2007, cargo-screening provision S. 467, FACT Act, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions H. R. 1, Implementing the 9/11 Commission Recommendations Act of 2007, cargo-screening provision H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions

Lobbyist	Covered position, as disclosed
PAUL BRATHWAITE	EXEC. DIR., CONGRESSIONAL BLACK CAUCUS
SHARON COHEN	N/A
RANDALL GERARD	N/A
COURTNEY HAGEN	N/A
AMANDA HUNTLEY	N/A
ANDREW KAUDERS	SR. ADV. SEN. MENENDEZ; ED, HOUSE DEM CAUCUS
ELIZABETH ANN MORRA	N/A
ANTHONY PODESTA	N/A
ANNE MARIE POLAK	LEG. CORRESPONDENT FOR REP. MIKE FERGUSON
LANTIE SLENZAK	LEGISLATIVE DIRECTOR, REP. GENE GREEN

Contacted: Food & Drug Administration (FDA); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1561 (110th), S. 623 (110th), S. 1156 (110th), S. 467 (110th), S. 596 (110th), S. 1695 (110th), S. 2029 (110th), S. 4 (110th), H.R. 1038 (110th), H.R. 1 (110th), S. 1082 (110th), S. 993 (110th), S. 1505 (110th), H.R. 1956 (110th), H.R. 3580 (110th), H.R. 2900 (110th), S. 1024 (110th), S. 242 (110th), S. 484 (110th)

Copyright/Patent/Trademark CPT

S. 1145, Patent Reform Act of 2007 H R. 1908, Patent Reform Act of 2007

Lobbyist	Covered position, as disclosed
PAUL BRATHWAITE	EXEC. DIR., CONGRESSIONAL BLACK CAUCUS
SHARON COHEN	N/A
RANDALL GERARD	N/A
COURTNEY HAGEN	N/A
AMANDA HUNTLEY	N/A
ANDREW KAUDERS	SR. ADV. SEN. MENENDEZ; ED, HOUSE DEM CAUCUS
ELIZABETH ANN MORRA	N/A
ANTHONY PODESTA	N/A
ANNE MARIE POLAK	LEG. CORRESPONDENT FOR REP. MIKE FERGUSON
LANTIE SLENZAK	LEGISLATIVE DIRECTOR, REP. GENE GREEN

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1145 (110th), H.R. 1908 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.